CUE
Cue Biopharma, Inc. · Healthcare
Director Peter A Kiener sold $31K of Cue Biopharma, Inc.
Sold$30,586
$3.28Price
9,325Shares
−96%Stake
What CUE did after the filing
- The stock from Mon, Mar 27 close, $93.60
- +55.4%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the May 9 close.
Traded Thu, Mar 23. Filed Mon, Mar 27, 12:05 PM ET, during the session. Returns use the Mar 27 close and the May 9 close. Not investment advice.